Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1998-7-15
pubmed:abstractText
Although in cord blood (CB) transplantation graft-versus-host disease (GVHD) is reported to be less severe, GVHD may occur even in patients with HLA-identical sibling donors. This result shows that HLA typing can not entirely predict GVHD. The standard MLR with CB cells was either normal or slightly reduced compared with adult peripheral blood (PB) cells. We used two manipulations to increase the responses of CB cells to allo-antigens. The first was to treat the stimulator cells with cytokines, and the second to amplify weak proliferative responses by adding exogenous cytokines to MLR cultures (modified MLR). The stimulator cells were treated with both interferon-gamma (IFN-gamma) and IL-4. The responder cells were treated with both IL-2 and tumour necrosis factor-alpha (TNF-alpha). It is still to be determined whether or not this cytokine-enhanced MLR could be a possible predictor of GVHD. However, using these cytokines, 90% of CB could recognize allo-antigens, even if the standard MLR was negative.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-1348434, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-1438190, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-1515873, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-1902399, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-1994250, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-1994541, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-2571931, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-2804362, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-3279117, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-7534135, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-7599566, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-7616801, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-7652763, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-7892281, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-7947291, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-8118883, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-8197610, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-8476573, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-8532022, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-8657213, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-9012937, http://linkedlifedata.com/resource/pubmed/commentcorrection/9649215-9326208
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
112
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
459-63
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Cytokine-enhanced mixed lymphocyte reaction (MLR) in cord blood.
pubmed:affiliation
Department of Pediatrics and Clinical Immunology, Mie University School of Medicine, Tsu, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't